Publications by authors named "Anna Dirner"

Claim this Profile
R
Real-world performance analysis of a universal computational reasoning model for precision oncology in lung cancer.
Anna Dirner, Dóra Kormos, Dóra Lakatos, Márton Bolyácz, Mária Kocsis-Steinbach

NPJ Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Barbara Vodicska, Júlia Déri, Dóra Tihanyi, Edit Várkondi, Enikő Kispéter, Anna Dirner

World J Pediatr· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors.
Barbara Vodicska, Júlia Déri, Dóra Tihanyi, Edit Várkondi, Enikő Kispéter, Anna Dirner

World J Pediatr· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With Mutation and Amplification Achieved by Dual Trametinib and Metformin Therapy.
Éva Remenár, Róbert Dóczi, Anna Dirner, Anna Sipos, Anita Perjési

JCO Precis Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support.
Judita Szkukalek, Róbert Dóczi, Anna Dirner, Ákos Boldizsár, Ágnes Varga

Diagnostics (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.
Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi

NPJ Precis Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, -Positive, -Mutant NSCLC.
László Urbán, Róbert Dóczi, Barbara Vodicska, Dóra Kormos, László Tóth, Anna Dirner

J Pers Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis